The history of Sildenafil presents a complex case for investors in the drug sector. While initially a tremendous success, creating vast sums, the intellectual property end and the subsequent flood of off-brand competitors have drastically affected revenue. This presents questions about the ongoing viability of analogous medication innovations an… Read More